{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:11:16Z","timestamp":1791983476181,"version":"4.4.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Genetic and non-genetic factors contribute to breast cancer development. An epigenome-based signature capturing these components in easily accessible samples could identify women at risk. Here, we analyse the DNA methylome in 2,818 cervical, 357 and 227 matched buccal and blood samples respectively, and 42 breast tissue samples from women with and without breast cancer. Utilising cervical liquid-based cytology samples, we develop the DNA methylation-based Women\u2019s risk IDentification for Breast Cancer index (WID-BC-index) that identifies women with breast cancer with an AUROC (Area Under the Receiver Operator Characteristic) of 0.84 (95% CI: 0.80\u20130.88) and 0.81 (95% CI: 0.76\u20130.86) in internal and external validation sets, respectively. CpGs at progesterone receptor binding sites hypomethylated in normal breast tissue of women with breast cancer or in <jats:italic>BRCA<\/jats:italic> mutation carriers are also hypomethylated in cervical samples of women with poor prognostic breast cancer. Our data indicate that a systemic epigenetic programming defect is highly prevalent in women who develop breast cancer. Further studies validating the WID-BC-index may enable clinical implementation for monitoring breast cancer risk.<\/jats:p>","DOI":"10.1038\/s41467-021-27918-w","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T17:03:16Z","timestamp":1643734996000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples"],"prefix":"10.1038","volume":"13","author":[{"given":"James E.","family":"Barrett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1572-498X","authenticated-orcid":false,"given":"Chiara","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1503-5535","authenticated-orcid":false,"given":"Olivia C.","family":"Leavy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iona","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Knapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Reisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4245-7346","authenticated-orcid":false,"given":"Tatiana","family":"Nazarenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0202-3228","authenticated-orcid":false,"given":"Yoo-Na","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorella","family":"Franchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Franks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line","family":"Bj\u00f8rge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5266-8895","authenticated-orcid":false,"given":"Michal","family":"Zikan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6387-9356","authenticated-orcid":false,"given":"David","family":"Cibula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9744-7372","authenticated-orcid":false,"given":"Nadia","family":"Harbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8817-8908","authenticated-orcid":false,"given":"Frank","family":"Dudbridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Sundstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8588-6506","authenticated-orcid":false,"given":"Joakim","family":"Dillner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelique Fl\u00f6ter","family":"R\u00e5destad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6516-1444","authenticated-orcid":false,"given":"Kristina","family":"Gemzell-Danielsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0843-2468","authenticated-orcid":false,"given":"Nora","family":"Pashayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7778-8380","authenticated-orcid":false,"given":"Martin","family":"Widschwendter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,1]]},"reference":[{"key":"27918_CR1","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/S0140-6736(16)31891-8","volume":"389","author":"N Harbeck","year":"2017","unstructured":"Harbeck, N. & Gnant, M. Breast cancer. Lancet 389, 1134\u20131150 (2017).","journal-title":"Lancet"},{"key":"27918_CR2","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1056\/NEJMcp1101540","volume":"365","author":"E Warner","year":"2011","unstructured":"Warner, E. Clinical practice. Breast-cancer screening. N. Engl. J. Med 365, 1025\u20131032 (2011).","journal-title":"N. Engl. J. Med"},{"key":"27918_CR3","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41586-018-0703-0","volume":"563","author":"SY Shen","year":"2018","unstructured":"Shen, S. Y. et al. Sensitive tumour detection and classification using plasma cell-free DNA methylomes. Nature 563, 579\u2013583 (2018).","journal-title":"Nature"},{"key":"27918_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-017-0499-9","volume":"9","author":"M Widschwendter","year":"2017","unstructured":"Widschwendter, M. et al. Methylation patterns in serum DNA for early identification of disseminated breast cancer. Genome Med 9, 115 (2017).","journal-title":"Genome Med"},{"key":"27918_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ejca.2017.11.002","volume":"90","author":"P Autier","year":"2018","unstructured":"Autier, P. & Boniol, M. Mammography screening: A major issue in medicine. Eur. J. Cancer 90, 34\u201362 (2018).","journal-title":"Eur. J. Cancer"},{"key":"27918_CR6","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1093\/jnci\/djy013","volume":"110","author":"MH Gail","year":"2018","unstructured":"Gail, M. H. & Pfeiffer, R. M. Breast Cancer Risk Model Requirements for Counseling, Prevention, and Screening. J. Natl Cancer Inst. 110, 994\u20131002 (2018).","journal-title":"J. Natl Cancer Inst."},{"key":"27918_CR7","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/jnci\/djz113","volume":"112","author":"P Pal Choudhury","year":"2020","unstructured":"Pal Choudhury, P. et al. Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification. J. Natl Cancer Inst. 112, 278\u2013285 (2020).","journal-title":"J. Natl Cancer Inst."},{"key":"27918_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","volume":"393","author":"PA Cohen","year":"2019","unstructured":"Cohen, P. A., Jhingran, A., Oaknin, A. & Denny, L. Cervical cancer. Lancet 393, 169\u2013182 (2019).","journal-title":"Lancet"},{"key":"27918_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10478","volume":"7","author":"AE Teschendorff","year":"2016","unstructured":"Teschendorff, A. E. et al. DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer. Nat. Commun. 7, 10478 (2016).","journal-title":"Nat. Commun."},{"key":"27918_CR10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1056\/NEJM200007133430201","volume":"343","author":"P Lichtenstein","year":"2000","unstructured":"Lichtenstein, P. et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med 343, 78\u201385 (2000).","journal-title":"N. Engl. J. Med"},{"key":"27918_CR11","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ejca.2017.01.014","volume":"75","author":"S Ambatipudi","year":"2017","unstructured":"Ambatipudi, S. et al. DNA methylome analysis identifies accelerated epigenetic ageing associated with postmenopausal breast cancer susceptibility. Eur. J. Cancer 75, 299\u2013307 (2017).","journal-title":"Eur. J. Cancer"},{"key":"27918_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/gm567","volume":"6","author":"S Anjum","year":"2014","unstructured":"Anjum, S. et al. A BRCA1-mutation associated DNA methylation signature in blood cells predicts sporadic breast cancer incidence and survival. Genome Med 6, 47 (2014).","journal-title":"Genome Med"},{"key":"27918_CR13","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s10549-014-3209-y","volume":"148","author":"G Severi","year":"2014","unstructured":"Severi, G. et al. Epigenome-wide methylation in DNA from peripheral blood as a marker of risk for breast cancer. Breast Cancer Res Treat. 148, 665\u2013673 (2014).","journal-title":"Breast Cancer Res Treat."},{"key":"27918_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-015-0104-2","volume":"7","author":"K van Veldhoven","year":"2015","unstructured":"van Veldhoven, K. et al. Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosis. Clin. Epigenetics 7, 67 (2015).","journal-title":"Clin. Epigenetics"},{"key":"27918_CR15","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/jnci\/djt045","volume":"105","author":"Z Xu","year":"2013","unstructured":"Xu, Z. et al. Epigenome-wide association study of breast cancer using prospectively collected sister study samples. J. Natl Cancer Inst. 105, 694\u2013700 (2013).","journal-title":"J. Natl Cancer Inst."},{"key":"27918_CR16","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1158\/0008-5472.CAN-11-3157","volume":"72","author":"K Brennan","year":"2012","unstructured":"Brennan, K. et al. Intragenic ATM methylation in peripheral blood DNA as a biomarker of breast cancer risk. Cancer Res 72, 2304\u20132313 (2012).","journal-title":"Cancer Res"},{"key":"27918_CR17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1001\/jama.2020.9482","volume":"324","author":"RT Chlebowski","year":"2020","unstructured":"Chlebowski, R. T. et al. Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women\u2019s Health Initiative Randomized Clinical Trials. JAMA 324, 369\u2013380 (2020).","journal-title":"JAMA"},{"key":"27918_CR18","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/S1470-2045(13)70448-0","volume":"14","author":"M Widschwendter","year":"2013","unstructured":"Widschwendter, M. et al. The sex hormone system in carriers of BRCA1\/2 mutations: a case-control study. Lancet Oncol. 14, 1226\u20131232 (2013).","journal-title":"Lancet Oncol."},{"key":"27918_CR19","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nature09387","volume":"468","author":"D Schramek","year":"2010","unstructured":"Schramek, D. et al. Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. Nature 468, 98\u2013102 (2010).","journal-title":"Nature"},{"key":"27918_CR20","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nature20785","volume":"540","author":"H Hosseini","year":"2016","unstructured":"Hosseini, H. et al. Early dissemination seeds metastasis in breast cancer. Nature 540, 552\u2013558 (2016).","journal-title":"Nature"},{"key":"27918_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature09495","volume":"468","author":"E Gonzalez-Suarez","year":"2010","unstructured":"Gonzalez-Suarez, E. et al. RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. Nature 468, 103\u2013107 (2010).","journal-title":"Nature"},{"key":"27918_CR22","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nature09091","volume":"465","author":"PA Joshi","year":"2010","unstructured":"Joshi, P. A. et al. Progesterone induces adult mammary stem cell expansion. Nature 465, 803\u2013807 (2010).","journal-title":"Nature"},{"key":"27918_CR23","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1126\/science.1130471","volume":"314","author":"AJ Poole","year":"2006","unstructured":"Poole, A. J. et al. Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist. Science 314, 1467\u20131470 (2006).","journal-title":"Science"},{"key":"27918_CR24","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nrclinonc.2018.30","volume":"15","author":"M Widschwendter","year":"2018","unstructured":"Widschwendter, M. et al. Epigenome-based cancer risk prediction: rationale, opportunities and challenges. Nat. Rev. Clin. Oncol. 15, 292\u2013309 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"27918_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1066-1","volume":"17","author":"R Pidsley","year":"2016","unstructured":"Pidsley, R. et al. Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling. Genome Biol. 17, 208 (2016).","journal-title":"Genome Biol."},{"key":"27918_CR26","doi-asserted-by":"publisher","first-page":"925","DOI":"10.2217\/epi-2018-0037","volume":"10","author":"SC Zheng","year":"2018","unstructured":"Zheng, S. C. et al. A novel cell-type deconvolution algorithm reveals substantial contamination by immune cells in saliva, buccal and cervix. Epigenomics 10, 925\u2013940 (2018).","journal-title":"Epigenomics"},{"key":"27918_CR27","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker, K. B. et al. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers. JAMA 317, 2402\u20132416 (2017).","journal-title":"JAMA"},{"key":"27918_CR28","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/nrg.2016.13","volume":"17","author":"AP Feinberg","year":"2016","unstructured":"Feinberg, A. P., Koldobskiy, M. A. & Gondor, A. Epigenetic modulators, modifiers and mediators in cancer aetiology and progression. Nat. Rev. Genet 17, 284\u2013299 (2016).","journal-title":"Nat. Rev. Genet"},{"key":"27918_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-018-1510-5","volume":"19","author":"A Salhab","year":"2018","unstructured":"Salhab, A. et al. A comprehensive analysis of 195 DNA methylomes reveals shared and cell-specific features of partially methylated domains. Genome Biol. 19, 150 (2018).","journal-title":"Genome Biol."},{"key":"27918_CR30","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1158\/1055-9965.EPI-11-0009","volume":"20","author":"L Mellemkjaer","year":"2011","unstructured":"Mellemkjaer, L. et al. Risk of primary non-breast cancer after female breast cancer by age at diagnosis. Cancer Epidemiol. Biomark. Prev. 20, 1784\u20131792 (2011).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"27918_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ajhg.2018.11.002","volume":"104","author":"N Mavaddat","year":"2019","unstructured":"Mavaddat, N. et al. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. Am. J. Hum. Genet 104, 21\u201334 (2019).","journal-title":"Am. J. Hum. Genet"},{"key":"27918_CR32","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s10549-021-06185-9","volume":"188","author":"PJ Ho","year":"2021","unstructured":"Ho, P. J. et al. DNA methylation and breast cancer-associated variants. Breast Cancer Res Treat. 188, 713\u2013727 (2021).","journal-title":"Breast Cancer Res Treat."},{"key":"27918_CR33","doi-asserted-by":"publisher","first-page":"11512","DOI":"10.1074\/jbc.M008556200","volume":"276","author":"D Lacasa","year":"2001","unstructured":"Lacasa, D., Le Liepvre, X., Ferre, P. & Dugail, I. Progesterone stimulates adipocyte determination and differentiation 1\/sterol regulatory element-binding protein 1c gene expression. potential mechanism for the lipogenic effect of progesterone in adipose tissue. J. Biol. Chem. 276, 11512\u201311516 (2001).","journal-title":"J. Biol. Chem."},{"key":"27918_CR34","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/ijc.22202","volume":"120","author":"M Esslimani-Sahla","year":"2007","unstructured":"Esslimani-Sahla, M. et al. Increased expression of fatty acid synthase and progesterone receptor in early steps of human mammary carcinogenesis. Int J. Cancer 120, 224\u2013229 (2007).","journal-title":"Int J. Cancer"},{"key":"27918_CR35","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3389\/fendo.2020.00596","volume":"11","author":"N Argov-Argaman","year":"2020","unstructured":"Argov-Argaman, N., Raz, C. & Roth, Z. Progesterone Regulation of Milk Fat Globule Size Is VLDL Dependent. Front Endocrinol. (Lausanne) 11, 596 (2020).","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"27918_CR36","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nature14583","volume":"523","author":"H Mohammed","year":"2015","unstructured":"Mohammed, H. et al. Progesterone receptor modulates ERalpha action in breast cancer. Nature 523, 313\u2013317 (2015).","journal-title":"Nature"},{"key":"27918_CR37","doi-asserted-by":"publisher","first-page":"e29021","DOI":"10.1371\/journal.pone.0029021","volume":"7","author":"P Yin","year":"2012","unstructured":"Yin, P. et al. Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. PLoS ONE 7, e29021 (2012).","journal-title":"PLoS ONE"},{"key":"27918_CR38","doi-asserted-by":"crossref","unstructured":"Widschwendter, M. & Dubeau, L. Non-Surgical Cancer Risk Reduction in BRCA1 Mutation Carriers: Disabling the Remote Control. Cancers (Basel) 12, 547 (2020).","DOI":"10.3390\/cancers12030547"},{"key":"27918_CR39","doi-asserted-by":"publisher","first-page":"e1919536","DOI":"10.1001\/jamanetworkopen.2019.19536","volume":"3","author":"JK Kresovich","year":"2020","unstructured":"Kresovich, J. K. et al. Prediagnostic Immune Cell Profiles and Breast Cancer. JAMA Netw. Open 3, e1919536 (2020).","journal-title":"JAMA Netw. Open"},{"key":"27918_CR40","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/S0140-6736(87)92206-9","volume":"1","author":"JA Haggie","year":"1987","unstructured":"Haggie, J. A., Sellwood, R. A., Howell, A., Birch, J. M. & Schor, S. L. Fibroblasts from relatives of patients with hereditary breast cancer show fetal-like behaviour in vitro. Lancet 1, 1455\u20131457 (1987).","journal-title":"Lancet"},{"key":"27918_CR41","doi-asserted-by":"publisher","first-page":"9327","DOI":"10.1073\/pnas.1604558113","volume":"113","author":"ME Levine","year":"2016","unstructured":"Levine, M. E. et al. Menopause accelerates biological aging. Proc. Natl Acad. Sci. USA 113, 9327\u20139332 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"27918_CR42","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1089\/bio.2013.0068","volume":"12","author":"N Perskvist","year":"2014","unstructured":"Perskvist, N., Bjorklund, C. & Dillner, J. A complex intervention for workflow enhancement at the Swedish cervical cytology biobank. Biopreserv Biobank 12, 69\u201373 (2014).","journal-title":"Biopreserv Biobank"},{"key":"27918_CR43","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/bio.2012.0036","volume":"11","author":"N Perskvist","year":"2013","unstructured":"Perskvist, N., Norman, I., Eklund, C., Litton, J. E. & Dillner, J. The Swedish cervical cytology biobank: sample handling and storage process. Biopreserv Biobank 11, 19\u201324 (2013).","journal-title":"Biopreserv Biobank"},{"key":"27918_CR44","first-page":"e22","volume":"45","author":"W Zhou","year":"2017","unstructured":"Zhou, W., Laird, P. W. & Shen, H. Comprehensive characterization, annotation and innovative use of Infinium DNA methylation BeadChip probes. Nucleic Acids Res 45, e22 (2017).","journal-title":"Nucleic Acids Res"},{"key":"27918_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-019-1466-7","volume":"17","author":"B Van Calster","year":"2019","unstructured":"Van Calster, B. et al. Calibration: the Achilles heel of predictive analytics. BMC Med 17, 230 (2019).","journal-title":"BMC Med"},{"key":"27918_CR46","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet 81, 559\u2013575 (2007).","journal-title":"Am. J. Hum. Genet"},{"key":"27918_CR47","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1093\/bioinformatics\/btq559","volume":"26","author":"A Manichaikul","year":"2010","unstructured":"Manichaikul, A. et al. Robust relationship inference in genome-wide association studies. Bioinformatics 26, 2867\u20132873 (2010).","journal-title":"Bioinformatics"},{"key":"27918_CR48","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/ng.3656","volume":"48","author":"S Das","year":"2016","unstructured":"Das, S. et al. Next-generation genotype imputation service and methods. Nat. Genet 48, 1284\u20131287 (2016).","journal-title":"Nat. Genet"},{"key":"27918_CR49","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature24284","volume":"551","author":"K Michailidou","year":"2017","unstructured":"Michailidou, K. et al. Association analysis identifies 65 new breast cancer risk loci. Nature 551, 92\u201394 (2017).","journal-title":"Nature"},{"key":"27918_CR50","unstructured":"Herzog. C., B. J., Widschwendter M. The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples. Nat. Commun 7, 10478 (2021)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27918-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27918-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27918-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T15:54:23Z","timestamp":1669305263000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27918-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["27918"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-27918-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,1]]},"assertion":[{"value":"20 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"UCLB (UCL\u2019s commercialisation company) has filed a patent (\u201cMethods for detecting and predicting cancer\u201d\u2014Application Number N418732GB) on breast cancer detection and risk prediction as described in the paper\u2014M.W. and J.E.B. are named as inventors on this patent. J.E.B., C.H. and M.W. are shareholders of Sola Diagnostics GmbH, which holds an exclusive licence to the intellectual property that protects the commercialisation of the WID-BC test. All other authors declare no competing interests relevant to the content of this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"449"}}